Author

Elisabeth Lamers

Observed names: E Lamers, E. Lamers

Institutions: Queen's University Belfast, Mayo Clinic, Almac (United Kingdom)

Observed institutions: Queen's University Belfast, Mayo Clinic, Almac (United Kingdom)

OpenAlex ID: A5061735206

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer

2011 · Judith E. Carser, Jennifer E. Quinn, et al. · Gynecologic Oncology · 65

PARP inhibition induces BAX/BAK‐independent synthetic lethality of BRCA1‐deficient non‐small cell lung cancer

2011 · Ian Paul, Kienan I Savage, et al. · The Journal of Pathology · 35

Microarray based expression profiling of BRCA1 mutated human tumours using a breast-specific platform to identify a profile of BRCA1 deficiency

2010 · E Lamers, FA McDyer, et al. · Breast Cancer Research · 4

PD10-05: Identification of Novel BRCA1 Transcriptional Targets That Promote the Survival of BRCA1-Mutated Estrogen Receptor-a Negative (ER-ve) Breast Tumours.

2011 · E Lamers, P Haddock, et al. · Cancer Research

The effect of PARP inhibition on BAX/BAK independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.

2011 · I. Paul, K. Savage, et al. · Journal of Clinical Oncology

Abstract P6-04-14: Impact of Estrogen Receptor Alpha Signalling in the Molecular Profiling of FFPE Derived BRCAl-Deficient Breast Tumours

2010 · JE Quinn, E Lamers, et al. · Cancer Research

630 Microarray based expression profiling of BRCA1 mutated breast tumours using a breast cancer specific array to identify a profile of BRCA1-deficiency

2010 · E. Lamers, G.W. Irwin, et al. · European Journal of Cancer Supplements

Works count: 7

Citation count: 104

H-index: 3

I10-index: 2